References
- Mancardi G. Further data on autologous haemopoietic stem cell transplantation in multiple sclerosis. Lancet Neurol.8(3), 219–221 (2009).
- Burt RK, Loh Y, Cohen B et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a Phase I/II study. Lancet Neurol.8(3), 244–253 (2009).
- Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J. Immunol.148(6), 1693–1698 (1992).
- van Gelder M, Kinwel-Bohré EP, van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant.11(3), 233–241 (1993).
- Marmont AM. Will hematopoietic stem cell transplantation cure human autoimmune diseases? J. Autoimmun.30(3), 145–150 (2008).
- Fassas A, Anagnostopoulos A, Kazis A et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant.20(8), 631–638 (1997).
- Roccatagliata L, Rocca M, Valsasina P et al. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. Mult. Scler.13(8), 1068–1070 (2007).
- Metz I, Lucchinetti CF, Openshaw H et al. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain130(Pt 5), 1254–1262 (2007).
- Hamerschlak N, Rodrigues M, Moraes DA et al. Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG. Bone Marrow Transplant.45(2), 239–248 (2010).
- Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from Phase I/II studies, prospective randomized trials and future directions. Clin. Exp. Immunol.141(1), 1–9 (2005).